APA

Michallet M., Socié G., Mohty M., Sobh M., Bay J., Morisset S., Labussière-Wallet H., Tabrizi R., Milpied N., Bordigoni P., El-Cheikh J. & Blaise D. (20130419). Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study. : Experimental hematology.

Chicago

Michallet Mauricette, Socié Gerard, Mohty Mohamad, Sobh Mohamad, Bay Jacques-O, Morisset Stéphane, Labussière-Wallet Hélène, Tabrizi Reza, Milpied Noel, Bordigoni Pierre, El-Cheikh Jean and Blaise Didier. 20130419. Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study. : Experimental hematology.

Harvard

Michallet M., Socié G., Mohty M., Sobh M., Bay J., Morisset S., Labussière-Wallet H., Tabrizi R., Milpied N., Bordigoni P., El-Cheikh J. and Blaise D. (20130419). Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study. : Experimental hematology.

MLA

Michallet Mauricette, Socié Gerard, Mohty Mohamad, Sobh Mohamad, Bay Jacques-O, Morisset Stéphane, Labussière-Wallet Hélène, Tabrizi Reza, Milpied Noel, Bordigoni Pierre, El-Cheikh Jean and Blaise Didier. Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study. : Experimental hematology. 20130419.